cy 208-243 has been researched along with racemetirosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peterson, MR; Robertson, HA; Worth, GG | 1 |
| Edwards, SR; Jackson, DM; Ross, SB; Wallis, EM | 1 |
2 other study(ies) available for cy 208-243 and racemetirosine
| Article | Year |
|---|---|
Synergistic and persistent interaction between the D2 agonist, bromocriptine, and the D1 selective agonist, CY 208-243.
Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Dopamine Agents; Drug Synergism; Indoles; Male; Methyltyrosines; Mice; Motor Activity; Phenanthridines; Receptors, Dopamine D1; Reserpine | 1992 |
Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Appetite Depressants; Benzazepines; Central Nervous System; Corpus Striatum; Ergolines; Indoles; Male; Methyltyrosines; Mice; Motor Activity; Phenanthridines; Quinpirole; Receptors, Dopamine; Reserpine; Stereotyped Behavior | 1988 |